MentalHealthDaily

Pharmaceutical & Recreational Drug Use During & After COVID-19 Pandemic (2020-2023 in Latvia) (2024 Study)

by GLOOM

The COVID-19 pandemic has undeniably transformed various facets of human life, including our health behaviors and substance consumption patterns. Through the lens of wastewater-based epidemiology (WBE), a study conducted in Riga, Latvia, from December 2020 to July 2023, sheds light on how the pandemic and subsequent restrictions have impacted the use of pharmaceuticals and recreational …

Xylopic Acid for Depression: May Increase Efficacy of Select Antidepressants via Synergistic Effect (2024 Study)

by GLOOM

In a new study, researchers discovered the synergistic antidepressant-like effects of xylopic acid (XA), a natural compound extracted from the dried fruits of Xylopia aethiopica, when combined with conventional antidepressants in mice. The study meticulously explored the interaction between XA and antidepressants like fluoxetine, sertraline, imipramine, and ketamine, revealing a promising potential for enhancing antidepressant …

Abnormal Brain EEG Activity Doesn’t Predict Antidepressant Efficacy in Depression (2023 Study)

by GLOOM

Depression is a multifaceted mental health condition that presents significant challenges in both diagnosis and treatment. Recent studies have explored the potential of electroencephalography (EEG) as a predictive tool for treatment outcomes in major depressive disorder (MDD), with particular focus on the response to antidepressants like escitalopram. Highlights: EEG Abnormalities & Antidepressant Response: Contrary to …

Natural Plant Polysaccharides for Depression: Antidepressant Mechanisms & Effects (2024 Review)

by GLOOM

Depression is a complex mental health disorder that affects millions of people worldwide, presenting a significant challenge for current medical treatments due to various side effects and drug resistances associated with conventional antidepressants. In response, researchers have turned their attention to natural plant polysaccharides, which have shown promising antidepressant effects through diverse mechanisms. This exploration …

Sex-Specific Biomarkers in Antidepressant Treatment for Depression: Male vs. Female (2023 Review)

by GLOOM

Depression, a complex and multifaceted disorder, presents differently in men and women, not only in symptoms but also in how each sex/gender responds to treatment. This divergence has led scientists to explore the molecular mechanisms behind these differences, revealing intricate biological and neurochemical pathways. Highlights: Sex-Specific Prevalence and Symptoms: Women are twice as likely as …

Antidepressants & Iron Pathways: Targeting Ferroptosis to Treat Depression (2023 Review)

by GLOOM

Depression, a debilitating mental disorder, stands as a significant challenge to global health, potentially becoming the leading cause of disability worldwide. Recent research has unearthed a promising connection between ferroptosis, a newly discovered form of cell death, and the onset of depression, offering fresh avenues for developing innovative antidepressant therapies. Traditional Chinese Medicine (TCM) and …

SSRI-Induced Sexual Dysfunction Reversed with “Drug Holidays” on Weekends (2024 Study)

by GLOOM

Selective serotonin reuptake inhibitors (SSRIs) are a mainstay in the treatment of various mental disorders but often come with the unwelcome side effect of sexual dysfunction. This issue can significantly affect patients’ adherence to their medication regime, often leading to treatment discontinuation. A recent clinical trial offers a new perspective, suggesting that ‘drug holidays’ – …